BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 26683142)

  • 1. Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.
    Harris JE
    Immunol Rev; 2016 Jan; 269(1):11-25. PubMed ID: 26683142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune mechanisms in vitiligo: danger from within.
    Richmond JM; Frisoli ML; Harris JE
    Curr Opin Immunol; 2013 Dec; 25(6):676-82. PubMed ID: 24238922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding autoimmunity of vitiligo and alopecia areata.
    Rork JF; Rashighi M; Harris JE
    Curr Opin Pediatr; 2016 Aug; 28(4):463-9. PubMed ID: 27191524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an autoimmune pathogenesis of vitiligo.
    Ongenae K; Van Geel N; Naeyaert JM
    Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis.
    Das D; Akhtar S; Kurra S; Gupta S; Sharma A
    Cytokine Growth Factor Rev; 2019 Feb; 45():35-44. PubMed ID: 30773437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?
    Namazi MR
    Pigment Cell Res; 2007 Oct; 20(5):360-3. PubMed ID: 17850509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and immune system in vitiligo and thyroid diseases.
    Colucci R; Dragoni F; Moretti S
    Oxid Med Cell Longev; 2015; 2015():631927. PubMed ID: 25838868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
    Lam-Tse WK; Lernmark A; Drexhage HA
    Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune etiology of generalized vitiligo.
    Le Poole IC; Luiten RM
    Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo: Mechanistic insights lead to novel treatments.
    Frisoli ML; Harris JE
    J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
    al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
    J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.